Allergy Therapeutics plc (AGY) Given "Buy" Rating at Panmure Gordon

‘s stock had its “buy” rating reaffirmed by stock analysts at Panmure Gordon in a research note issued to investors on Tuesday, Market Beat Ratings reports. They presently have a GBX 51 price objective on the stock.